Resilience Therapeutics Overview

  • Founded
  • 2015

Founded
  • Status
  • Out of Business

  • Employees
  • 8

Employees
  • Latest Deal Type
  • Out of Business

Resilience Therapeutics General Information

Description

Operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditions including PTSD and Social Anxiety Disorder. The company is focused on developing therapeutics that provide both symptom relief and potential disease modification for PTSD and other Stress-Related Disorders, providing medical practitioners with first-in-class therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma-related disorders.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Boston, MA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resilience Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 31-Dec-2021 00.000 Completed Out of Business
2. Seed Round 03-Mar-2016 00000 00.000 Completed Generating Revenue
1. Seed Round 30-Jul-2015 $2.92M $2.92M 00.00 Completed Generating Revenue
To view Resilience Therapeutics’s complete valuation and funding history, request access »

Resilience Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view Resilience Therapeutics’s complete cap table history, request access »

Resilience Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditi
Drug Discovery
Boston, MA
8 As of 2016
00.000
00000000 00 00.000

000000

on ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit i
0000 000000000
Niel, Belgium
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000

modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugi
0000 000000000
Boston, MA
0 As of 0000
000.00
000000 - 000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Resilience Therapeutics Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
eTheRNA Venture Capital-Backed Niel, Belgium 00 00000 00000000000 00000
0000000 0000000000 Venture Capital-Backed Boston, MA 0 000.00 000000 - 000 000.00
000000 00000000000 Venture Capital-Backed Bethlehem, PA 000.00 0000000000 000.00
0000000 0000000000 Formerly PE-Backed Cambridge, MA 000 0000 000000000 0000
0000000 Venture Capital-Backed Hannover, Germany 00 00000 00000000000 00000
You’re viewing 5 of 24 competitors. Get the full list »

Resilience Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial